JP2000506005A5 - - Google Patents

Download PDF

Info

Publication number
JP2000506005A5
JP2000506005A5 JP1997530180A JP53018097A JP2000506005A5 JP 2000506005 A5 JP2000506005 A5 JP 2000506005A5 JP 1997530180 A JP1997530180 A JP 1997530180A JP 53018097 A JP53018097 A JP 53018097A JP 2000506005 A5 JP2000506005 A5 JP 2000506005A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997530180A
Other languages
English (en)
Japanese (ja)
Other versions
JP4082733B2 (ja
JP2000506005A (ja
Filing date
Publication date
Priority claimed from US08/604,333 external-priority patent/US5776731A/en
Application filed filed Critical
Publication of JP2000506005A publication Critical patent/JP2000506005A/ja
Publication of JP2000506005A5 publication Critical patent/JP2000506005A5/ja
Application granted granted Critical
Publication of JP4082733B2 publication Critical patent/JP4082733B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP53018097A 1996-02-21 1997-02-06 2f1と呼ばれる受容体タンパク質 Expired - Fee Related JP4082733B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/604,333 US5776731A (en) 1996-02-21 1996-02-21 DNA encoding type-I interleukin-I receptor-like protein designated 2F1
US08/604,333 1996-02-21
PCT/US1997/001697 WO1997031010A1 (en) 1996-02-21 1997-02-06 Receptor protein designated 2f1

Publications (3)

Publication Number Publication Date
JP2000506005A JP2000506005A (ja) 2000-05-23
JP2000506005A5 true JP2000506005A5 (cg-RX-API-DMAC7.html) 2005-03-10
JP4082733B2 JP4082733B2 (ja) 2008-04-30

Family

ID=24419190

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53018097A Expired - Fee Related JP4082733B2 (ja) 1996-02-21 1997-02-06 2f1と呼ばれる受容体タンパク質

Country Status (12)

Country Link
US (8) US5776731A (cg-RX-API-DMAC7.html)
EP (1) EP1007537B1 (cg-RX-API-DMAC7.html)
JP (1) JP4082733B2 (cg-RX-API-DMAC7.html)
AT (1) ATE368682T1 (cg-RX-API-DMAC7.html)
AU (1) AU720943B2 (cg-RX-API-DMAC7.html)
CA (1) CA2245496C (cg-RX-API-DMAC7.html)
DE (2) DE69737978T2 (cg-RX-API-DMAC7.html)
DK (1) DK1007537T3 (cg-RX-API-DMAC7.html)
ES (1) ES2287950T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ331176A (cg-RX-API-DMAC7.html)
PT (1) PT1007537E (cg-RX-API-DMAC7.html)
WO (1) WO1997031010A1 (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776731A (en) * 1996-02-21 1998-07-07 Immunex Corporation DNA encoding type-I interleukin-I receptor-like protein designated 2F1
JP4024366B2 (ja) * 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド
US7141393B2 (en) * 1996-12-26 2006-11-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18-receptor proteins
JP3955352B2 (ja) 1997-02-25 2007-08-08 株式会社林原生物化学研究所 破骨細胞形成阻害剤
US6087116A (en) * 1997-03-12 2000-07-11 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interleukin-18 (IL-18) receptor polypeptides and their uses
EP0980432A1 (en) * 1997-05-01 2000-02-23 Amgen, Inc. Chimeric opg polypeptides
US7393663B2 (en) * 1997-08-01 2008-07-01 Serono Genetics Institute S.A. Expressed sequence tags and encoded human proteins
US7220717B2 (en) * 1997-08-14 2007-05-22 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
US7704944B2 (en) * 1997-08-14 2010-04-27 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis
US6326472B1 (en) * 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods
CA2318482C (en) 1998-01-23 2010-04-13 Immunex Corporation Il-18 receptors
CA2276216A1 (en) * 1998-06-24 1999-12-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo An artificial peptide capable of neutralizing the biological activity of interleukin-18
US7029861B1 (en) 1998-09-15 2006-04-18 Board Of Regents, The University Of Texas System LPS-response gene compositions and methods
US6472179B2 (en) * 1998-09-25 2002-10-29 Regeneron Pharmaceuticals, Inc. Receptor based antagonists and methods of making and using
JP3538616B2 (ja) * 2000-04-25 2004-06-14 友昭 星野 間質性肺炎治療薬および当該疾病の動物モデルの作成方法並びにそれを用いるスクリーニング方法
AU2001259758A1 (en) * 2000-05-12 2001-11-26 Immunex Corporation Interleukin-1 inhibitors in the treatment of diseases
AU2002224417A1 (en) * 2000-10-18 2002-04-29 Immunex Corporation Methods for treating il-18 mediated disorders
JP4696382B2 (ja) * 2001-03-21 2011-06-08 アイシン精機株式会社 三本鎖dnaの形成方法
WO2003072740A2 (en) * 2002-02-25 2003-09-04 Genentech, Inc. Novel type-1 cytokine receptor glm-r
US20040136992A1 (en) 2002-08-28 2004-07-15 Burton Paul B. J. Compositions and method for treating cardiovascular disease
AU2005264453B2 (en) * 2004-07-16 2011-07-14 Atsuo Sekiyama IL-18 receptor antagonist and pharmaceutical composition containing the antagonist
AU2011226823B2 (en) * 2004-07-16 2012-09-20 Atsuo Sekiyama IL-18 receptor antagonist and pharmaceutical composition containing the antagonist
WO2007096398A1 (en) * 2006-02-22 2007-08-30 University Of Zurich Soluble receptors and methods for treating autoimmune or demyelinating diseases
CL2008002153A1 (es) 2007-07-24 2009-06-05 Amgen Inc Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
PH12014500329A1 (en) 2011-08-15 2014-04-14 Abbott Laboaratories Process for manufacturing hmb and salts thereof
CN113645991A (zh) * 2019-02-08 2021-11-12 西达-赛奈医疗中心 靶向il18r1的、用于治疗炎性疾病的方法、系统和试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989004838A1 (en) * 1987-11-25 1989-06-01 Immunex Corporation Interleukin-1 receptors
US5853721A (en) * 1995-01-31 1998-12-29 Hoffmann-La Roche Inc. Antibody to interleukin-12 receptor
US5776731A (en) * 1996-02-21 1998-07-07 Immunex Corporation DNA encoding type-I interleukin-I receptor-like protein designated 2F1
US6326472B1 (en) * 1997-10-15 2001-12-04 Schering Corporation Human receptor proteins; related reagents and methods

Similar Documents

Publication Publication Date Title
JP2001505052A5 (cg-RX-API-DMAC7.html)
JP2000502280A5 (cg-RX-API-DMAC7.html)
JP2000501771A5 (cg-RX-API-DMAC7.html)
JP2000513608A5 (cg-RX-API-DMAC7.html)
JP2000501018A5 (cg-RX-API-DMAC7.html)
JP2000500076A5 (cg-RX-API-DMAC7.html)
JP2001504244A5 (cg-RX-API-DMAC7.html)
JP2000501324A5 (cg-RX-API-DMAC7.html)
JP2000500055A5 (cg-RX-API-DMAC7.html)
JP2000500026A5 (cg-RX-API-DMAC7.html)
JP2000502472A5 (cg-RX-API-DMAC7.html)
JP2000501338A5 (cg-RX-API-DMAC7.html)
JP2000501825A5 (cg-RX-API-DMAC7.html)
JP2001505643A5 (cg-RX-API-DMAC7.html)
JP2000500874A5 (cg-RX-API-DMAC7.html)
JP2000508208A5 (cg-RX-API-DMAC7.html)
JP2000502425A5 (cg-RX-API-DMAC7.html)
JP2001504470A5 (cg-RX-API-DMAC7.html)
JP2001504376A5 (cg-RX-API-DMAC7.html)
JP2000501774A5 (cg-RX-API-DMAC7.html)
JP2000500912A5 (cg-RX-API-DMAC7.html)
JP2001502415A5 (cg-RX-API-DMAC7.html)
JP2000501876A5 (cg-RX-API-DMAC7.html)
JP2000501744A5 (cg-RX-API-DMAC7.html)
JP2000501229A5 (cg-RX-API-DMAC7.html)